查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1985602

人工授精市場：依動物種類、授精方法、精液來源及最終使用者分類－2026-2032年全球市場預測

Artificial Insemination Market by Animal Type, Insemination Technique, Source of Sperm, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，人工授精市場價值將達到 37.1 億美元，到 2026 年將成長至 40.2 億美元，到 2032 年將達到 68.4 億美元，複合年成長率為 9.13%。

主要市場統計數據
基準年 2025 37.1億美元
預計年份：2026年 40.2億美元
預測年份 2032 68.4億美元
複合年成長率 (%) 9.13%

畜牧業人工授精技術的全面實施：聚焦創新、關鍵挑戰及在生產力和疾病管理方面的策略價值

人工授精已從一項小眾的獸醫服務發展成為現代畜牧系統中提高生產力、改良遺傳品種和保障生物安全的戰略工具。如今，從業者和商業人士都將繁殖技術視為畜群管理不可或缺的一部分，其影響範圍涵蓋農場層面的生產力、國家育種計劃以及國際遺傳資源貿易。精液處理、冷凍保存和妊娠診斷技術的進步拓展了生產者可獲得的服務範圍，但管理體制和動物健康通訊協定仍在不斷影響著相關實踐的開展方式。

基因組學、精準育種工具、數位受孕分析以及對永續性的關注，正在重塑人工授精產業，帶來變革性的轉變。

在基因組學、精準育種和數位分析等突破性進展的推動下，人工授精領域正經歷著一場變革。基因組選擇縮短了遺傳改良週期，實現了更精準的牛選擇，並加速了優良性狀的傳播。同時，精液性別分選和冷凍保存技術的進步正在改變生產者規劃育種週期和管理牛群組成的方式。除了這些技術進步之外，利用育種模型、機器學習和即時監測的決策支援工具也使得人工授精時機的最佳化和結果預測的可靠性顯著提高。

2025 年美國關稅變化對人工授精供應鏈、跨境遺傳資源貿易和生殖經濟的累積影響分析。

美國2025年實施的關稅調整將對遺傳資源貿易、設備採購和服務經濟產生累積影響，但不會改變生殖技術的基本需求促進因素。關稅帶來的成本壓力可能會推高進口精液、冷凍保存設備和專用耗材的到貨價格，從而影響育種公司和服務供應商的籌資策略。為此，供應鏈將進行重組。各公司將重新審視其供應商組合，加快國內採購產品的認證，並重新思考其庫存策略，以應對突如其來的成本衝擊。

透過細分洞察動物物種和品種層級類別如何影響人工授精實踐、服務提供模式以及跨物種的價值。

市場區隔有助於深入了解不同動物物種和品種等級的需求和服務差異，以及商業策略為何必須根據物種特有的生物學特性和生產者的經濟狀況客製化。本研究涵蓋牛、家禽、綿羊/山羊和牛，每種動物都有其獨特的運行節奏和育種通訊協定，這些都會影響人工授精服務的設計。對於牛，本研究區分了肉牛和乳牛養殖，並認知到產量目標、發情週期和每頭犢牛的價值會影響其優先事項。本研究也檢視了牛的子類別，例如安格斯牛和赫里福德牛，其中性狀選擇和市場導向決定了牛的使用和遺傳育種計劃。牛的育種決策受到高價值荷斯坦牛和澤西牛品種遺傳特性的影響，這些品種推動了對生育力監測和精液品管的投資。

對美洲、歐洲、中東和非洲以及亞太地區的人工授精採用、監管和供應鏈韌性進行區域分析。

區域環境對人工授精服務的採用模式、監管方式及商業生態係有顯著影響。在美洲，成熟的商業性育種計畫和一體化的供應鏈為先進基因的推廣提供了支持，但生產者在生物安全標準和物流方面面臨區域差異，這影響了服務的提供。歐洲、中東和非洲地區的管理體制和市場成熟度呈現多元化的特徵。嚴格的動物健康框架和可追溯性要求與新興市場並存，在這些新興市場中，能力建設和知識轉移正在推動早期成長。在亞太地區，高密度生產區域以及精準畜牧技術的快速應用，催生了對可擴展解決方案和區域性育種策略的需求。

從企業層面深入了解育種者、遺傳資源提供者和生殖技術領導者之間的競爭定位、夥伴關係和專業化程度。

在公司層面，趨勢揭示了技術能力、服務產品和策略夥伴關係之間的相互作用，這些因素共同塑造了人工授精生態系統中的競爭優勢。領先的遺傳資源供應商和專業服務公司正在投資垂直整合能力，將牛選擇、精液處理和分銷網路相結合，以確保產品品質並縮短交付時間。與生物技術公司、獸醫服務機構和精密農業軟體供應商的策略合作，正在加速基因組和數據驅動的進步向商業性產品和服務的快速轉化。

為領導者提供切實可行的建議，以加快採用速度、增強供應韌性、最佳化遺傳資源管道，並使業務營運與數位化和永續發展目標保持一致。

希望在不斷發展的人工授精市場中獲利的企業領導者應實施一系列重點營運措施，以平衡短期韌性和中期成長。首先，優先考慮供應商關係多元化，並探索區域精液加工和本地夥伴關係，以降低跨境中斷和關稅影響的風險。其次，加速採用成熟的生殖分析和監測工具，以提高受孕率，並提供可衡量的服務水準指標，從而證明提供加值服務的合理性。第三，投資提升人力資源能力，透過規範人工授精負責人和獸醫技術人員的培訓，並建構可擴展、可複製的服務模式，同時確保服務品質。

調查方法結合了與專家的初步訪談、實地檢驗、供應鏈映射和混合方法分析，得出了可操作且可靠的見解。

本分析所依據的研究整合了多種證據來源，以確保其穩健性和實用性。研究方法首先是對生殖技術、冷凍保存和基因組學領域的科學文獻進行廣泛回顧，隨後對獸醫、育種專案經理、物流專家和設備供應商進行結構化訪談。實地檢驗包括對典型生產基地進行現場考察和營運評估，以觀察服務提供模式、精液處理流程以及農民的採納行為。此外，研究還透過梳理法律規範、進出口要求和已發布的技術標準，補充了原始資訊。

總結了相關人員在調整育種計劃、夥伴關係和投資方面的策略意義、風險因素和機會途徑。

總之，人工授精領域正處於一個轉折點，技術創新、政策趨勢和不斷變化的生產者期望交織在一起，迫使服務模式和競爭定位進行重組。遺傳學和數位化育種管理工具的進步為提高生產力和改善動物健康提供了清晰的路徑，而區域和貿易因素則要求採取靈活的供應鏈策略。將基因組分析的精準性與穩健的營運管理、透明的可追溯性和有針對性的人才培養相結合的相關人員，將更有利於創造價值並降低風險。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：人工授精市場：依動物類型分類

  • 牛
    • 牛
      • 安格斯
      • 赫里福德
    • 乳製品
      • 荷斯坦
      • 球衣
  • 家禽
    • 肉雞
    • 取卵
  • 綿羊/山羊
    • 山羊
    • 羊
  • 豬
    • 商業的
    • 本地物種

第9章 依授精方式分類的人工授精市場

  • 子宮頸內人工授精
  • 子宮內人工授精
  • 輸卵管內人工授精

第10章：以精子供應來源分類的人工授精市場

  • 捐精
  • 伴侶的精子

第11章 人工授精市場：依最終用戶分類

  • 不孕症治療診所
  • 醫院
  • 居家照護

第12章：人工授精市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：人工授精市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 人工授精市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國人工授精市場

第16章 中國人工授精市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Carl Zeiss AG
  • Cook Medical Inc.
  • CooperSurgical Inc.
  • Corning incorporated
  • Esco micro pte. Ltd.
  • Ferring BV
  • FertiPro NV
  • Genea Biomedx Pty Ltd.
  • Hamilton Thorne, Inc.
  • INVO Bioscience, Inc.
  • IVFtech ApS
  • Kitazato Corporation
  • Laboratoire CCD
  • Meiji Techno Co., Ltd.
  • Merck KGaA
  • Nidacon International AB
  • Nikon Corporation
  • Olympus Corporation
  • Thermo Fisher Scientific Inc.
  • Vitrolife AB
Product Code: MRR-A37FCEE11759

The Artificial Insemination Market was valued at USD 3.71 billion in 2025 and is projected to grow to USD 4.02 billion in 2026, with a CAGR of 9.13%, reaching USD 6.84 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.71 billion
Estimated Year [2026] USD 4.02 billion
Forecast Year [2032] USD 6.84 billion
CAGR (%) 9.13%

Comprehensive introduction to artificial insemination in livestock highlighting innovations, key challenges and strategic value for productivity, disease control

Artificial insemination has evolved from a niche veterinary service into a strategic lever for productivity, genetic improvement and biosecurity across modern livestock systems. Practitioners and commercial operators now view reproductive technologies as an integral part of herd and flock management, with implications that extend from farm-level productivity to national breeding programs and international genetics trade. Advances in semen processing, cryopreservation, and fertility diagnostics have expanded the scope of services available to producers, while regulatory regimes and animal health protocols continue to shape operational practices.

Transitioning from historical practices, the sector increasingly integrates veterinary sciences, genetics, and digital monitoring to optimize reproductive outcomes. Veterinary professionals, breeding cooperatives and private genetics companies collaborate to deliver tailored programs aimed at improving conception rates, reducing disease transmission and accelerating genetic gain. At the same time, producers demand demonstrable returns on reproductive investments, prompting service providers to refine pricing, training and performance measurement. As stakeholders navigate this landscape, clarity around technology adoption pathways, compliance obligations and value realization becomes essential for both short-term operational decisions and longer-term strategic planning.

Transformative shifts reshaping artificial insemination led by genomics, precision breeding tools, digital fertility analytics and sustainability priorities

The landscape of artificial insemination is undergoing transformative shifts driven by breakthroughs in genomics, precision breeding and digital analytics. Genomic selection has shortened the cycle for genetic improvement, enabling more accurate sire selection and accelerating the dissemination of desirable traits. Concurrently, sex-sorted semen and enhancements in cryopreservation chemistry are changing how producers plan breeding cycles and manage herd composition. These technical advances are complemented by decision-support tools that apply fertility modeling, machine learning and real-time monitoring to optimize insemination timing and predict outcomes with greater reliability.

Beyond the laboratory, structural changes in service delivery are emerging. Decentralized semen distribution, mobile insemination units and increased outsourcing of reproductive services are reshaping the commercial model. These shifts respond to producer preferences for on-demand services and turnkey solutions that reduce labor burdens while maintaining biosecurity standards. Sustainability has also become a decisive factor, with stakeholders assessing carbon intensity and resource efficiency alongside genetic performance. As the sector converges around these technological and operational trends, businesses that combine validated reproductive science with robust digital tools and service models will hold a competitive advantage in meeting evolving producer expectations.

Cumulative impact analysis of United States tariff changes in 2025 on artificial insemination supply chains, cross-border genetics trade and breeding economics

The introduction of tariff adjustments in the United States during 2025 has a cumulative effect that reverberates through genetics trade, equipment sourcing and service economics without altering the underlying demand drivers for reproductive technologies. Tariff-induced cost pressures tend to raise the landed price of imported semen, cryogenic equipment and specialized consumables, which in turn affects procurement strategies among breeding companies and service providers. In response, supply chains reconfigure: firms review supplier portfolios, accelerate qualification of domestic inputs and reconsider inventory strategies to buffer against episodic cost shocks.

Policy shifts also influence trade flows for elite genetics. When cross-border movement of germplasm becomes more expensive, stakeholders may prioritize domestic sire programs or intensify collaboration with regional genetic suppliers to preserve access to desired traits. At the same time, tariff dynamics can spur investment in local processing capacity-such as onshore semen packaging and cryopreservation facilities-if the economics support it. Finally, regulatory and compliance frictions tied to trade policy amplify the need for clear documentation and traceability, prompting firms to invest in logistics, certification workflows and risk management measures that reduce exposure to tariff volatility and ensure continuity of breeding programs.

Segmentation insights into how animal type and breed-level categories shape artificial insemination practices, service delivery models and value across species

Segmentation provides a lens to understand how demand and service delivery vary across animal types and breed hierarchies, and why commercial strategies must be tailored to species-specific biology and producer economics. The market is studied across cattle, poultry, sheep and goats, and swine, with each animal type exhibiting distinct operational rhythms and reproductive protocols that influence the design of insemination services. Within cattle, the study differentiates beef and dairy operations, recognizing that production objectives, cycle cadence and value per offspring shape priorities. Beef subcategories examined include Angus and Hereford, where trait selection and market orientation determine sire utilization and genetic programs. Dairy breeding decisions hinge on high-value Holstein and Jersey genetics, which drive investments in fertility monitoring and semen quality controls.

Poultry is evaluated through broiler and layer systems, where integration with hatcheries and large-scale incubation changes the service architecture for reproductive inputs. Sheep and goats are analyzed through discrete goat and sheep programs, each with specific flock management patterns, while swine segmentation contrasts commercial and indigenous populations, exposing divergent needs for genetic improvement versus conservation. Collectively, these layers of segmentation reveal how breed-level differentiation and production system design drive product development, pricing strategies and extension services for insemination providers seeking to serve diverse client needs.

Regional insights on adoption, regulation and supply chain resilience in artificial insemination across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional context strongly conditions adoption patterns, regulatory approaches and the shape of commercial ecosystems for insemination services. In the Americas, established commercial breeding programs and integrated supply chains support advanced genetics dissemination, yet producers face regional variance in biosecurity standards and logistics that alter service delivery. Europe, Middle East & Africa presents a mosaic of regulatory regimes and market maturity; stringent animal health frameworks and traceability expectations coexist with emerging markets where capacity building and knowledge transfer drive early-stage growth. Asia-Pacific combines high-density production zones with rapid adoption of precision livestock technologies, creating demand for scalable solutions and region-specific breeding strategies.

As a result, firms must align investment and operational models to regional realities. In mature markets, emphasis shifts toward service differentiation, data-driven fertility optimization and premium genetics, while capacity building, localized training and infrastructure support are more relevant in developing regions. Cross-border collaboration, regional hubs for semen processing and standardized compliance workflows can reduce friction and enable faster technology diffusion. Ultimately, regional nuances inform both go-to-market planning and the prioritization of local partnerships that facilitate scalable, compliant and cost-effective service rollout.

Company-level insights into competitive positioning, partnerships and specialization among breeders, genetics providers and reproductive technology leaders

Company-level dynamics reveal the interplay between technology capability, service reach and strategic partnerships that shape competitive advantage in the insemination ecosystem. Leading genetics providers and specialized service companies invest in vertically integrated capabilities-combining sire selection, semen processing and distribution networks-to ensure product quality and shorten delivery timelines. Strategic alliances with biotechnology firms, veterinary service groups and precision agriculture software vendors accelerate the translation of genomic and data-driven advances into commercially viable offerings.

Smaller, agile enterprises differentiate through niche specialization: focused breed programs, regionally optimized logistics or bundled on-farm services that include training and performance guarantees. Collaboration between established breeders and emerging technology providers also yields hybrid models that leverage scale while introducing innovation. Across the board, companies that pair robust quality assurance processes with transparent traceability and demonstrable service outcomes create trust with producers and command preferential engagement. Investment priorities among firms commonly center on cryopreservation technology, data platforms for fertility analytics and workforce training to ensure consistent execution at the farm level.

Practical recommendations for leaders to accelerate adoption, fortify supply resilience, optimize genetics pipelines and align operations with digital and sustainability goals

Leaders seeking to capture opportunity in the evolving insemination market should pursue a set of focused, operational steps that balance immediate resilience with medium-term growth. First, prioritize diversification of supplier relationships and consider regional processing or localized partnerships to reduce exposure to cross-border disruptions and tariff sensitivity. Second, accelerate adoption of proven fertility analytics and monitoring tools to improve conception outcomes and provide measurable service-level metrics that justify premium offerings. Third, invest in workforce capability by standardizing training for inseminators and veterinary technicians, creating a reproducible service model that scales without sacrificing quality.

In parallel, companies should develop clear sustainability narratives linked to breeding outcomes, resource efficiency and animal welfare to meet buyer expectations and support market differentiation. Engage proactively with regulators to shape practical compliance pathways that facilitate trade while protecting animal health. Finally, explore modular commercial models-such as subscription services, performance-linked contracts or bundled genetics and advisory packages-that align producer incentives with long-term genetic improvement and generate recurring revenue streams for providers.

Research methodology combining primary expert interviews, field validation, supply chain mapping and mixed-method analysis to produce actionable and credible insights

The research underpinning this analysis combined multiple evidence streams to ensure robustness and practical relevance. The approach began with an extensive review of scientific literature on reproductive technologies, cryopreservation and genomics, followed by structured interviews with veterinarians, breeding program managers, logistics specialists and equipment suppliers. Field validation included site visits and operational assessments to observe service delivery models, semen handling protocols and farmer adoption behaviors in representative production settings. Secondary sources supplemented primary inputs by mapping regulatory frameworks, import/export requirements and published technical standards.

Methodologically, the study applied mixed-method synthesis: qualitative insights from expert interviews contextualized quantitative indicators derived from supply chain observation and transactional patterns. Scenarios were developed to test sensitivity to policy shifts and supply disruptions, and findings were triangulated with practitioner feedback to refine recommendations. Throughout, the research emphasized transparency of assumptions and traceability of data to support reproducibility and enable tailored follow-up analyses for specific species or regions.

Conclusion summarizing strategic implications, risk considerations and opportunity pathways for stakeholders adapting breeding programs, partnerships and investments

In conclusion, the artificial insemination sector stands at an inflection point where technological innovation, policy dynamics and evolving producer expectations converge to reshape service models and competitive positioning. Genetic advances and digital fertility tools offer clear pathways to enhanced productivity and improved animal health, while regional and trade considerations require agile supply chain strategies. Stakeholders who integrate genomic precision with robust operational controls, transparent traceability and targeted workforce development will be best positioned to capture value and mitigate risk.

The cumulative lessons emphasize the need for pragmatic investment decisions that prioritize validated performance outcomes, regional alignment and sustainable practices. By combining strategic supplier diversification, focused technology adoption and collaborative regulatory engagement, organizations can translate the sector's technical progress into durable commercial advantage and meaningful improvements in livestock production outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Insemination Market, by Animal Type

  • 8.1. Cattle
    • 8.1.1. Beef
      • 8.1.1.1. Angus
      • 8.1.1.2. Hereford
    • 8.1.2. Dairy
      • 8.1.2.1. Holstein
      • 8.1.2.2. Jersey
  • 8.2. Poultry
    • 8.2.1. Broiler
    • 8.2.2. Layer
  • 8.3. Sheep & Goats
    • 8.3.1. Goats
    • 8.3.2. Sheep
  • 8.4. Swine
    • 8.4.1. Commercial
    • 8.4.2. Indigenous

9. Artificial Insemination Market, by Insemination Technique

  • 9.1. Intracervical Insemination
  • 9.2. Intrauterine Insemination
  • 9.3. Intratubal Insemination

10. Artificial Insemination Market, by Source of Sperm

  • 10.1. Donor Sperm
  • 10.2. Partner Sperm

11. Artificial Insemination Market, by End User

  • 11.1. Fertility Clinics
  • 11.2. Hospitals
  • 11.3. Home-care

12. Artificial Insemination Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Artificial Insemination Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Artificial Insemination Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Artificial Insemination Market

16. China Artificial Insemination Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Carl Zeiss AG
  • 17.6. Cook Medical Inc.
  • 17.7. CooperSurgical Inc.
  • 17.8. Corning incorporated
  • 17.9. Esco micro pte. Ltd.
  • 17.10. Ferring B.V.
  • 17.11. FertiPro N.V.
  • 17.12. Genea Biomedx Pty Ltd.
  • 17.13. Hamilton Thorne, Inc.
  • 17.14. INVO Bioscience, Inc.
  • 17.15. IVFtech ApS
  • 17.16. Kitazato Corporation
  • 17.17. Laboratoire CCD
  • 17.18. Meiji Techno Co., Ltd.
  • 17.19. Merck KGaA
  • 17.20. Nidacon International AB
  • 17.21. Nikon Corporation
  • 17.22. Olympus Corporation
  • 17.23. Thermo Fisher Scientific Inc.
  • 17.24. Vitrolife AB

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL INSEMINATION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ARTIFICIAL INSEMINATION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY ANGUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY ANGUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY ANGUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HEREFORD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HEREFORD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HEREFORD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOLSTEIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOLSTEIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOLSTEIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY JERSEY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY JERSEY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY JERSEY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY BROILER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY BROILER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY BROILER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY LAYER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY LAYER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY LAYER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY GOATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY GOATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY GOATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY COMMERCIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INDIGENOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INDIGENOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INDIGENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRACERVICAL INSEMINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRACERVICAL INSEMINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRACERVICAL INSEMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRATUBAL INSEMINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRATUBAL INSEMINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRATUBAL INSEMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR SPERM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR SPERM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR SPERM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY PARTNER SPERM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY PARTNER SPERM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY PARTNER SPERM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY FERTILITY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY FERTILITY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOME-CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOME-CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOME-CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 188. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 189. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 190. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 192. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 194. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 195. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 221. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 222. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 223. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 224. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 225. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 227. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 228. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 232. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 233. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 234. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 235. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 236. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 238. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 239. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)